Influenza A Virus Hemagglutinin vs Tofacitinib

## Influenza A Virus Hemagglutinin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Influenza A Virus Hemagglutinin** and **Tofacitinib**.

## Mechanism of Action

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Influenza A Virus Hemagglutinin — N/A; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Influenza A Virus Hemagglutinin — N/A; Tofacitinib — C16H20N6O.

**Molecular Weight**: Influenza A Virus Hemagglutinin — N/A; Tofacitinib — 312.3700 g/mol.

**Type**: Influenza A Virus Hemagglutinin — Vaccine component; Tofacitinib — Small molecule.